| Development of a translational model to assess the impact of opioid overdose and naloxone dosing on respiratory depression and cardiac arrest J Mann, M Samieegohar, A Chaturbedi, J Zirkle, X Han, SF Ahmadi, ... Clinical Pharmacology & Therapeutics 112 (5), 1020-1032, 2022 | 38 | 2022 |
| Compartment based population balance model development of a high shear wet granulation process via dry and wet binder addition A Chaturbedi, CK Bandi, D Reddy, P Pandey, A Narang, D Bindra, L Tao, ... Chemical Engineering Research and Design 123, 187-200, 2017 | 26 | 2017 |
| A parallel unidirectional coupled DEM-PBM model for the efficient simulation of computationally intensive particulate process systems C Sampat, F Bettencourt, Y Baranwal, I Paraskevakos, A Chaturbedi, ... Computers & Chemical Engineering 119, 128-142, 2018 | 18 | 2018 |
| Adsorption of positively and negatively charged heavy metal ions from wastewater by heteroaggregates of biopolymer particles A Chaturbedi, S Patil, R Ramachandran, NC Shapley Colloids and Surfaces A: Physicochemical and Engineering Aspects 602, 124789, 2020 | 14 | 2020 |
| A compartment based population balance model for the prediction of steady and induction granule growth behavior in high shear wet granulation I Muthancheri, A Chaturbedi, A Bétard, R Ramachandran Advanced Powder Technology 32 (6), 2085-2096, 2021 | 11 | 2021 |
| Population balance model development and experimental validation for the heteroaggregation of oppositely charged micro-and nano-particles A Chaturbedi, C Pathak, K Deshpande, N Shapley, R Ramachandran Chemical Engineering Research and Design 113, 96-111, 2016 | 11 | 2016 |
| Parallelization methods for efficient simulation of high dimensional population balance models of granulation FE Bettencourt, A Chaturbedi, R Ramachandran Computers & Chemical Engineering 107, 158-170, 2017 | 9 | 2017 |
| Predictive population balance model development and validation of the effect of high shear wet granulation process parameters on granule properties A Chaturbedi, P Pandey, D Bindra, JP Reddy, B Lang, D Buckley, ... Powder Technology 338, 391-401, 2018 | 8 | 2018 |
| Intranasal Naloxone Repeat Dosing Strategies and Fentanyl Overdose: A Simulation-Based Randomized Clinical Trial DG Strauss, Z Li, A Chaturbedi, S Chakravartula, M Samieegohar, J Mann, ... JAMA Network Open 7 (1), e2351839-e2351839, 2024 | 7 | 2024 |
| Calibration and Validation of a Mechanistic COVID‐19 Model for Translational Quantitative Systems Pharmacology–A Proof‐of‐Concept Model Development for Remdesivir M Samieegohar, JL Weaver, KE Howard, A Chaturbedi, J Mann, X Han, ... Clinical Pharmacology & Therapeutics 112 (4), 882-891, 2022 | 5 | 2022 |
| Deep learning-enabled natural language processing to identify directional pharmacokinetic drug–drug interactions J Zirkle, X Han, R Racz, M Samieegohar, A Chaturbedi, J Mann, ... BMC bioinformatics 24 (1), 413, 2023 | 4 | 2023 |
| A combined computational and experimental study of the heteroaggregation of dissimilar adsorbent particles AK Chaturbedi Rutgers University-School of Graduate Studies, 2019 | 2 | 2019 |
| Harnessing large language models’ zero-shot and few-shot learning capabilities for regulatory research H Meshkin, J Zirkle, G Arabidarrehdor, A Chaturbedi, S Chakravartula, ... Briefings in Bioinformatics 25 (5), bbae354, 2024 | 1 | 2024 |
| Mechanism-based organization of neural networks to emulate systems biology and pharmacology models J Mann, H Meshkin, J Zirkle, X Han, B Thrasher, A Chaturbedi, ... Scientific Reports 14 (1), 12082, 2024 | 1 | 2024 |
| Physiologically based modeling reveals different risk of respiratory depression after fentanyl overdose between adults and children S Chakravartula, B Thrasher, J Mann, A Chaturbedi, X Han, A Dahan, ... Clinical and Translational Science 17 (4), e13780, 2024 | 1 | 2024 |
| Toward Developing Alternative Opioid Antagonists for Treating Community Overdose: A Model‐Based Evaluation of Important Pharmacological Attributes A Chaturbedi, J Mann, S Chakravartula, B Thrasher, G Arabidarrehdor, ... Clinical Pharmacology & Therapeutics, 0 | | |
